(444) - IgM Enriched Human Immunoglobulins and Rituximab Nullify the Mortality Risk Associated with Early Donor Specific Antibodies After Lung Transplantation.

Subjects

Subjects :

*LUNG transplantation
*RITUXIMAB
*IMMUNOGLOBULIN M
*ORGAN donors
*GRAFT rejection
*MORTALITY

Details

Language :

English

ISSN :

10532498

Volume :

35

Database :

Academic Search Index

Journal :

Journal of Heart & Lung Transplantation

Publication Type :

Academic Journal

Accession number :

114574490

Full Text :

https://doi.org/10.1016/j.healun.2016.01.471